A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19
Abstract
Aims: We carried out this prospective study of predominantly non-severe COVID-19 patients, to evaluate the influence of glycaemic status on clinical outcomes and neutralising antibody (Nab) responses, potentially relevant to the COVID-19 vaccination programme.
Citation
Lui, D. T. W., Li, Y. K., Lee, C. H., Chow, W. S., Lee, A. C. H., Tam, A. R., … Lam, K. S. L. (2022, March). A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19. Diabetes Research and Clinical Practice. Elsevier BV. http://doi.org/10.1016/j.diabres.2022.109232
Resource Type
Addition Details
Date:
2022-03-01
Wave of COVID:
5th
Category:
Source URL:
Share